Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 2 | 0 |
| May 2026 | 6 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 21:22 UTC |
Arduini Peter JDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 129,140 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001323134-26-000010 · wk-form4_1772659337.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,140 Underlying: Common Stock, par value $0.01 per share · 129,140 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:22 UTC |
Arduini Peter JDirector · President and CEO
|
GrantCommon Stock, par value $0.01 per share | 49,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001323134-26-000010 · wk-form4_1772659337.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,255 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC |
SACCARO JAMESChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 32,797 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001593636-26-000006 · wk-form4_1772659390.xml · derivative · entry 2 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,797 Underlying: Common Stock, par value $0.01 per share · 32,797 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC |
SACCARO JAMESChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 12,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001593636-26-000006 · wk-form4_1772659390.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,161 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC |
Holton Adam YChief People Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 14,348 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001657919-26-000002 · wk-form4_1772659548.xml · derivative · entry 2 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,348 Underlying: Common Stock, par value $0.01 per share · 14,348 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC |
Holton Adam YChief People Officer
|
GrantCommon Stock, par value $0.01 per share | 5,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001657919-26-000002 · wk-form4_1772659548.xml · nonDerivative · entry 1 Holton Adam Y · CIK 0001657919 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,225 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:26 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 34,847 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001960652-26-000006 · wk-form4_1772659574.xml · derivative · entry 2 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,847 Underlying: Common Stock, par value $0.01 per share · 34,847 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:26 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantCommon Stock, par value $0.01 per share | 13,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001960652-26-000006 · wk-form4_1772659574.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,909 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,443 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001952158-26-000006 · wk-form4_1772659522.xml · derivative · entry 3 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,443 Underlying: Common Stock, par value $0.01 per share · 3,443 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:25 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantCommon Stock, par value $0.01 per share | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001952158-26-000006 · wk-form4_1772659522.xml · nonDerivative · entry 1 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,627 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC |
O'Neill Kevin MichaelCEO, PDx
|
GrantEmployee Stock Option (right to buy) · Derivative | 17,218 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001951605-26-000006 · wk-form4_1772659488.xml · derivative · entry 3 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,218 Underlying: Common Stock, par value $0.01 per share · 17,218 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:24 UTC |
O'Neill Kevin MichaelCEO, PDx
|
GrantCommon Stock, par value $0.01 per share | 6,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001951605-26-000006 · wk-form4_1772659488.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,744 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC |
Rott RolandCEO, Imaging
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,548 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001952159-26-000006 · wk-form4_1772659420.xml · derivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,548 Underlying: Common Stock, par value $0.01 per share · 22,548 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:23 UTC |
Rott RolandCEO, Imaging
|
GrantCommon Stock, par value $0.01 per share | 8,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001952159-26-000006 · wk-form4_1772659420.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,082 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC |
Rackliffe PhilipCEO, AVS
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,174 | $79.20 | $92,980.80 |
DisclosureSEC source: 0002027284-26-000004 · wk-form4_1771373829.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,373 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC |
Rackliffe PhilipCEO, AVS
|
GrantCommon Stock, par value $0.01 per share | 3,154 | $0.00 | $0.00 |
DisclosureSEC source: 0002027284-26-000004 · wk-form4_1771373829.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,547 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:15 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 8,357 | $79.20 | $661,874.40 |
DisclosureSEC source: 0001465175-26-000006 · wk-form4_1771373718.xml · nonDerivative · entry 2 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,267 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:15 UTC |
Jimenez Frank RGC & Corporate Secretary
|
GrantCommon Stock, par value $0.01 per share | 22,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001465175-26-000006 · wk-form4_1771373718.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,624 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:13 UTC |
Arduini Peter JDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.01 per share | 33,445 | $79.20 | $2,648,844.00 |
DisclosureSEC source: 0001323134-26-000008 · wk-form4_1771373612.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,135 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:13 UTC |
Arduini Peter JDirector · President and CEO
|
GrantCommon Stock, par value $0.01 per share | 74,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001323134-26-000008 · wk-form4_1771373612.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,580 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:14 UTC |
SACCARO JAMESChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 8,570 | $79.20 | $678,744.00 |
DisclosureSEC source: 0001593636-26-000004 · wk-form4_1771373665.xml · nonDerivative · entry 2 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,686 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:14 UTC |
SACCARO JAMESChief Financial Officer
|
GrantCommon Stock, par value $0.01 per share | 22,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001593636-26-000004 · wk-form4_1771373665.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,256 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:18 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 802 | $79.20 | $63,518.40 |
DisclosureSEC source: 0001952158-26-000004 · wk-form4_1771373900.xml · nonDerivative · entry 2 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,318 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:18 UTC |
Newcomb George A.Chief Accounting Officer
|
GrantCommon Stock, par value $0.01 per share | 2,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001952158-26-000004 · wk-form4_1771373900.xml · nonDerivative · entry 1 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,120 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,261 | $79.20 | $258,271.20 |
DisclosureSEC source: 0001951605-26-000004 · wk-form4_1771373867.xml · nonDerivative · entry 2 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,195 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:17 UTC |
O'Neill Kevin MichaelCEO, PDx
|
GrantCommon Stock, par value $0.01 per share | 6,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001951605-26-000004 · wk-form4_1771373867.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,456 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:16 UTC |
Rott RolandCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,943 | $79.20 | $312,285.60 |
DisclosureSEC source: 0001952159-26-000004 · wk-form4_1771373792.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,506 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:16 UTC |
Rott RolandCEO, Imaging
|
GrantCommon Stock, par value $0.01 per share | 7,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001952159-26-000004 · wk-form4_1771373792.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,449 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:15 UTC |
Kass-Hout TahaChief Technology Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 7,787 | $79.20 | $616,730.40 |
DisclosureSEC source: 0001960652-26-000004 · wk-form4_1771373747.xml · nonDerivative · entry 2 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,655 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:15 UTC |
Kass-Hout TahaChief Technology Officer
|
GrantCommon Stock, par value $0.01 per share | 23,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001960652-26-000004 · wk-form4_1771373747.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,442 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:02 UTC |
Rackliffe PhilipCEO, AVS
|
Tax withholdingCommon Stock, par value $0.01 per share | 189 | $78.97 | $14,925.33 |
DisclosureSEC source: 0002027284-26-000002 · wk-form4_1770163334.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,393 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:54 UTC |
Jimenez Frank RGC & Corporate Secretary
|
Tax withholdingCommon Stock, par value $0.01 per share | 947 | $78.97 | $74,784.59 |
DisclosureSEC source: 0001465175-26-000004 · wk-form4_1770162874.xml · nonDerivative · entry 1 Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,546 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:47 UTC |
Arduini Peter JDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,210 | $78.97 | $253,493.70 |
DisclosureSEC source: 0001323134-26-000006 · wk-form4_1770162439.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,672 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:51 UTC |
SACCARO JAMESChief Financial Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 948 | $78.97 | $74,863.56 |
DisclosureSEC source: 0001593636-26-000002 · wk-form4_1770162715.xml · nonDerivative · entry 1 SACCARO JAMES · CIK 0001593636 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,646 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:03 UTC |
O'Neill Kevin MichaelCEO, PDx
|
Tax withholdingCommon Stock, par value $0.01 per share | 462 | $78.97 | $36,484.14 |
DisclosureSEC source: 0001951605-26-000002 · wk-form4_1770163403.xml · nonDerivative · entry 1 O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,518 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 4, 2026 00:01 UTC |
Kass-Hout TahaChief Technology Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 847 | $78.97 | $66,887.59 |
DisclosureSEC source: 0001960652-26-000002 · wk-form4_1770163264.xml · nonDerivative · entry 1 Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,103 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:56 UTC |
Rott RolandCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 558 | $78.97 | $44,065.26 |
DisclosureSEC source: 0001952159-26-000002 · wk-form4_1770162996.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,564 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:58 UTC |
Newcomb George A.Chief Accounting Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 108 | $78.97 | $8,528.76 |
DisclosureSEC source: 0001952158-26-000002 · wk-form4_1770163090.xml · nonDerivative · entry 1 Newcomb George A. · CIK 0001952158 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,597 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC |
Rott RolandCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,614 | $0.00 Strike: $51.67 | $0.00 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · derivative · entry 6 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 1,614 shares Expires 2029-04-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023, of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC |
Rott RolandCEO, Imaging
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,727 | $0.00 Strike: $57.74 | $0.00 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · derivative · entry 5 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 3,727 shares Expires 2029-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023, of the distribution of approximately 80.1% of the shares of GE HealthCare common stock by GE to holders of GE common stock on a pro-rata basis, of which 100% was fully exercisable immediately. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC |
Rott RolandCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,352 | $76.68 | $103,671.36 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 4 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,122 F1 · shares: Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC |
Rott RolandCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 1,614 | $51.67 | $83,395.38 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 3 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC |
Rott RolandCEO, Imaging
|
Tax withholdingCommon Stock, par value $0.01 per share | 3,268 | $76.68 | $250,590.24 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 2 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,860 F1 · shares: Represents the number of shares withheld by GE HealthCare Technologies Inc. ("GE HealthCare") to satisfy the exercise price and tax withholding obligations in connection with the net settlement of the options, and does not represent a sale of any shares by the Reporting Person. Read SEC document |
| September 11, 2025 Filed Sep 12, 2025 20:05 UTC |
Rott RolandCEO, Imaging
|
Exercise / conversionCommon Stock, par value $0.01 per share | 3,727 | $57.74 | $215,196.98 |
DisclosureSEC source: 0001952159-25-000008 · wk-form4_1757707503.xml · nonDerivative · entry 1 Rott Roland · CIK 0001952159 · CEO, Imaging 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC |
Rackliffe PhilipCEO, AVS
|
Tax withholdingCommon Stock, par value $0.01 per share | 1,388 | $73.73 | $102,337.24 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 4 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,582 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC |
Rackliffe PhilipCEO, AVS
|
Tax withholdingCommon Stock, par value $0.01 per share | 204 | $73.73 | $15,040.92 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 3 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,970 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC |
Rackliffe PhilipCEO, AVS
|
Tax withholdingCommon Stock, par value $0.01 per share | 134 | $73.73 | $9,879.82 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 2 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,174 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:16 UTC |
Rackliffe PhilipCEO, AVS
|
Tax withholdingCommon Stock, par value $0.01 per share | 165 | $73.73 | $12,165.45 |
DisclosureSEC source: 0002027284-25-000006 · wk-form4_1756930572.xml · nonDerivative · entry 1 Rackliffe Philip · CIK 0002027284 · CEO, AVS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,308 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 16:19 UTC |
Stacherski Kenneth R.Chief Enterprise Oper. Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 434 | $73.73 | $31,998.82 |
DisclosureSEC source: 0001889865-25-000008 · wk-form4_1756930773.xml · nonDerivative · entry 2 Stacherski Kenneth R. · CIK 0001889865 · Chief Enterprise Oper. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,996 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 16:19 UTC |
Stacherski Kenneth R.Chief Enterprise Oper. Officer
|
Tax withholdingCommon Stock, par value $0.01 per share | 458 | $73.73 | $33,768.34 |
DisclosureSEC source: 0001889865-25-000008 · wk-form4_1756930773.xml · nonDerivative · entry 1 Stacherski Kenneth R. · CIK 0001889865 · Chief Enterprise Oper. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,430 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.